Table 1.
IC50 range | % (no.) of isolates |
||||||
---|---|---|---|---|---|---|---|
CQ | Quin | Mef | Hal | Art | Amo | Lum | |
Total | 100 (700) | 100 (698) | 100 (684) | 100 (690) | 100 (600) | 100 (370) | 100 (280) |
High | 53.4 (374) | 4.7 (33) | 20.2 (138) | 14.5 (100) | 4.8 (29) | 4.3 (16) | 27 (76) |
Intermediate | 9.1 (64) | 12.8 (89) | 21.6 (148) | 25.8 (178) | 3.4 (20) | 5.3 (20) | 7.1 (20) |
Low | 37.4 (262) | 82.5 (576) | 58.2 (398) | 39.7 (412) | 91.8 (551) | 90.4 (334) | 65.8 (184) |
Shown are percentages of isolates classified as resistant, intermediate, and susceptible based on the IC50 of each drug. Three classes were considered for each antimalarial. The IC50 cutoff for each class was as follows: CQ, chloroquine (high [resistant], IC50 of >100 nM; intermediate, 80 < IC50 < 100 nM; low [susceptible], IC50 of <80 nM); Quin, quinine (high [resistant], IC50 of >500 nM; intermediate, 300 < IC50 < 500 nM; low [susceptible], IC50 of <300 nM); Mef, mefloquine (high [resistant], IC50 of >30 nM; intermediate, 15 < IC50 < 30 nM; low [susceptible], IC50 of <15 nM); Hal, halofantrine (high, IC50 of >8 nM; intermediate, 4 < IC50 < 8 nM; low, IC50 of <4 nM); Art, artemether (high, IC50 of >12 nM; intermediate, 8 < IC50 < 12 nM; low, IC50 of <8 nM); Amo, monodesthyl-amodiaquine (high, IC50 of >60 nM; intermediate, 40 < IC50 < 60 nM; low, IC50 of <40 nM); Lum, lumefantrine (high, IC50 of >150 nM; intermediate, 100 < IC50 < 150 nM; low, IC50 of <100 nM).